Vanderbilt-Ingram Cancer Center

Lynn Matrisian, Ph.D., professor and chair of the Department of Cancer Biology and Ingram Distinguished Professor of Cancer Research, will leave her Vanderbilt post at the end of the year to accept the newly-created position as vice president of Research and Medical Affairs at the Pancreatic Cancer Action Network, based in Manhattan Beach, Calif. Harold [...]

May is National Cancer Research Month, and Vanderbilt-Ingram Cancer Center would like to take the opportunity to celebrate the hard work and dedication of scientists and researchers here and around the world. Jennifer A. Pietenpol, Ph.D., the Cancer Center’s director, said celebrating this observance is a way to advocate to the public about the importance [...]

Lynn Matrisian, Ph.D., chair of the Department of Cancer Biology, has been named to the Nominating Committee for the American Association for Cancer Research (AACR). The announcement was made during the AACR annual meeting held earlier this month in Orlando, Fla. Matrisian has served as AACR president from 2004-2005, as a member of the board [...]

After years of confusion about the safety of soy food consumption by breast cancer survivors, a large new study found that eating soy foods did not increase the risk of cancer recurrence or death among breast cancer survivors. The study was presented at the American Association for Cancer Research (AACR) annual meeting in Orlando, Fla. [...]

Breast cancer researchers gathered earlier this month for the annual San Antonio Breast Cancer Symposium. In this video interview with the American Association for Cancer Research, you will hear Vanderbilt-Ingram Cancer Center’s Dr. Carlos Arteaga discuss translational insights for clinical research and practice at the meeting, as well as his exciting research in women’s cancer as part of a Stand Up To Cancer “Dream Team.”

William Pao, M.D., Ph.D., associate professor of Medicine, Vanderbilt-Ingram Cancer Center, has been awarded a grant from Stand Up to Cancer (SU2C) to study molecules that could speed up the search for new cancer drugs and targets. He is one of 13 young cancer investigators to earn a grant from SU2C.